Preoperative hemostasis and its association with bleeding and blood component transfusion requirements in cardiopulmonary bypass surgery

Transfusion ◽  
2012 ◽  
Vol 53 (6) ◽  
pp. 1226-1234 ◽  
Author(s):  
Nahit Emeklibas ◽  
Inna Kammerer ◽  
Juergen Bach ◽  
Falk-Udo Sack ◽  
Peter Hellstern
1987 ◽  
Author(s):  
E Rocha ◽  
R Llorens ◽  
J A Paramo ◽  
R Arcas ◽  
B Cuesta ◽  
...  

It has been suggested that desmopressin acetate (DDAVP) administration reduces blood loss after cardiac surgery. We have investigated the effect of DDAVP administration in a doubleblind, randomized, prospective trial including 60 patients undergoing cardiopulmonary bypass surgery. Thirty patients received 0.3 ug/kg DDAVP and 30 patients a placebo. The infusion was administered in a 50 ml saline solution over 15 min when cardiopulmonary bypass had been concluded. Blood samples were taken before surgery, immediately before and 90 min after DDAVP or placebo administration, and 24 hours postoperatively. The following parameters were measured in each sample: hematocrit, hemoglobin, platelet count, VIII:C and factor VIII:vWF. Bleeding time was also measured before operation and 90 min after treatment administration. Blood loss and transfusion requirements were evaluated from the beginning of treatment until 72 hours after surgery. Results showed no significant differences neither in total blood loss (833 ± 363 ml in the DDAVP group vs. 907 ± 646 in the placebo group) nor in blood transfusion (1633 ± 676 ml in the DDAVP group vs. 1643 ± 720 in the placebo group). The prolongation of bleeding time and the decrease of factor VIII:vWF, 90 min after treatment, were significantly lower (p < 0.05) in the DDAVP group as compared with the placebo group. We conclude that DDAVP administration does not reduce blood loss in patients undergoing cardiopulmonary bypass surgery, which would suggest a more complex mechanism to explain the increased bleeding in these patients.


2005 ◽  
Vol 22 (Supplement 35) ◽  
pp. 1
Author(s):  
R. Whitty ◽  
D. Harney ◽  
M. OʼConnell ◽  
V. Young ◽  
E. McGovern ◽  
...  

Circulation ◽  
1997 ◽  
Vol 95 (5) ◽  
pp. 1242-1246 ◽  
Author(s):  
Thomas L. Bauer ◽  
Gowthami Arepally ◽  
Barbara A. Konkle ◽  
Bernadette Mestichelli ◽  
Sandor S. Shapiro ◽  
...  

2021 ◽  
Vol 16 (1) ◽  
Author(s):  
Chunnian Ren ◽  
Chun Wu ◽  
Zhengxia Pan ◽  
Quan Wang ◽  
Yonggang Li

Abstract Objectives The occurrence of pulmonary infection after congenital heart disease (CHD) surgery can lead to significant increases in intensive care in cardiac intensive care unit (CICU) retention time, medical expenses, and risk of death risk. We hypothesized that patients with a high risk of pulmonary infection could be screened out as early after surgery. Hence, we developed and validated the first risk prediction model to verify our hypothesis. Methods Patients who underwent CHD surgery from October 2012 to December 2017 in the Children’s Hospital of Chongqing Medical University were included in the development group, while patients who underwent CHD surgery from December 2017 to October 2018 were included in the validation group. The independent risk factors associated with pulmonary infection following CHD surgery were screened using univariable and multivariable logistic regression analyses. The corresponding nomogram prediction model was constructed according to the regression coefficients. Model discrimination was evaluated by the area under the receiver operating characteristic curve (ROC) (AUC), and model calibration was conducted with the Hosmer-Lemeshow test. Results The univariate and multivariate logistic regression analyses identified the following six independent risk factors of pulmonary infection after cardiac surgery: age, weight, preoperative hospital stay, risk-adjusted classification for congenital heart surgery (RACHS)-1 score, cardiopulmonary bypass time and intraoperative blood transfusion. We established an individualized prediction model of pulmonary infection following cardiopulmonary bypass surgery for CHD in children. The model displayed accuracy and reliability and was evaluated by discrimination and calibration analyses. The AUCs for the development and validation groups were 0.900 and 0.908, respectively, and the P-values of the calibration tests were 0.999 and 0.452 respectively. Therefore, the predicted probability of the model was consistent with the actual probability. Conclusions Identified the independent risk factors of pulmonary infection after cardiopulmonary bypass surgery. An individualized prediction model was developed to evaluate the pulmonary infection of patients after surgery. For high-risk patients, after surgery, targeted interventions can reduce the risk of pulmonary infection.


2005 ◽  
Vol 27 (4) ◽  
pp. 611-616 ◽  
Author(s):  
C LUYTEN ◽  
F VANOVERVELD ◽  
L DEBACKER ◽  
A SADOWSKA ◽  
I RODRIGUS ◽  
...  

Shock ◽  
1997 ◽  
Vol 7 (Supplement) ◽  
pp. 31
Author(s):  
H. Neuhof ◽  
R. Soeparwata ◽  
F. Dapper ◽  
C. Neuhof

Sign in / Sign up

Export Citation Format

Share Document